Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Argus Research Upgrades Biogen to Buy

Argus Research Upgrades Biogen to Buy

Argus Research analyst Jasper Hellweg upgrades Biogen (NASDAQ:BIIB) from Hold to Buy.

byBenzinga Newsdesk

October 7, 2022

1 minute read

Argus Research analyst Jasper Hellweg upgrades Biogen (NASDAQ:BIIB) from Hold to Buy.

Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

February 6, 1:58 PM

Gainers Secoo Holding Limited (NASDAQ: SECO) jumped 156% to $4.3600. Arqit Quantum Inc. (NASDAQ: ARQQ) gained 41.5% to $3.54.

ACON

‘Congress Sets Limits On Staff ChatGPT Use’ – Axios

By Benzinga Newsdesk

June 26, 12:55 PM

https://www.axios.com/2023/06/26/congress-rules-staff-chatgptThe House is placing new guardrails around use of the popular AI chatbot ChatGPT by congressional offices, Axios has learned.Why it matters: It's the latest

MSFT

RBC Capital Maintains Outperform on Brookfield Asset Mgmt, Raises Price Target to $40

By Benzinga Newsdesk

February 9, 9:59 AM

RBC Capital analyst Geoffrey Kwan maintains Brookfield Asset Mgmt (NYSE:BAM) with a Outperform and raises the price target from $35 to $40.

BAM

Analyst Ratings

Analyst Ratings for PayPal Holdings

By Benzinga Insights

December 5, 5:00 PM

Over the past 3 months, 21 analysts have published their opinion on PayPal Holdings (NASDAQ:PYPL) stock. These analysts…

PYPL

Argus Research Upgrades Biogen to Buy

Related Posts

Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

‘Congress Sets Limits On Staff ChatGPT Use’ – Axios

RBC Capital Maintains Outperform on Brookfield Asset Mgmt, Raises Price Target to $40

Analyst Ratings for PayPal Holdings